Matinas BioPharma's Angel Round

Matinas BioPharma raised a round of funding on May 17, 2013.

Matinas BioPharma (NYSE AMER:MTNB) is a clinical-stage biopharmaceutical company that aims to transform the way potent medicines are delivered and administered to provide physicians and patients with …

Articles about Matinas BioPharma's Angel Round: